CCR2 and neoplasm: In a murine CRC model, the antihypertensive agent reserpine is shown to block lactate-induced HCAR1 signaling, suppress the recruitment of CCR2 + PMN-MDSCs, restore CD8+ T cell-mediated antitumor immunity, and enhance tumor sensitivity to anti-PD-1 therapy [107].